NCT03827343View on ClinicalTrials.gov

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

January 23, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Macrophage Activation SyndromePrimary Hemophagocytic Lymphohistiocytosis

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT03827343 - Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer | Biotech Hunter | Biotech Hunter